Takata Osamu, Kawamura Yutaka J, Konishi Fumio, Sasaki Junichi, Kai Toshihiro, Miyakura Yasuyuki, Nagai Hideo, Tsukamoto Toshihiko
Department of Surgery, Omiya Medical Center, Jichi Medical School, 1-847 Amanuma, Saitama, Japan.
Surg Today. 2006;36(7):608-14. doi: 10.1007/s00595-006-3210-0.
Distant metastasis is a significant prognostic factor of colon carcinoma. Adjuvant chemotherapy has been shown to decrease its recurrence. However, there are no definitive methods for the diagnosis of hepatic recurrence after potentially curative surgery. The aim of this study was to evaluate the accuracy of mRNA expression profiling using samples obtained from primary tumors to predict hepatic recurrence.
Patients with stage III colorectal carcinoma without any recurrence for at least 5 years (group A: n = 9) and patients with stage IV carcinoma with hepatic metastasis (group B: n = 10) were included in this study. Tissue samples were collected from the primary tumor and adjacent normal colonic mucosa at the time of surgery in each patient. Total RNA was extracted and the mRNA expression profile was examined using a cDNA macroarray.
A hierarchical clustering analysis revealed a dendrogram in which the patients were divided into two clusters. One cluster consisted of seven patients in group A and two in group B. The other consisted of two patients in group A and eight in group B. Therefore, the positive and negative predictive value of hierarchical clustering analysis for hepatic metastasis was 80.0% and 78.8%, respectively. Fifteen genes were revealed to be upregulated and 12 were downregulated in group B. The upregulated genes included CCNA2, TP53, and MDM2, while the downregulated genes included CDH1, GADD45A, and BCL2L2.
mRNA expression profiling by a cDNA array analysis of specimens obtained from primary tumors was found to be useful for distinguishing patients with and without hepatic metastasis. This method is expected to contribute to the identification of patients at high risk for hepatic recurrence, while also helping in the administration of intensive adjuvant chemotherapy for such high risk patients.
远处转移是结肠癌的一个重要预后因素。辅助化疗已被证明可降低其复发率。然而,对于潜在根治性手术后肝转移复发尚无明确的诊断方法。本研究的目的是评估利用原发肿瘤样本进行mRNA表达谱分析预测肝转移复发的准确性。
本研究纳入了至少5年无任何复发的III期结直肠癌患者(A组:n = 9)和伴有肝转移的IV期癌患者(B组:n = 10)。在每位患者手术时从原发肿瘤和相邻正常结肠黏膜采集组织样本。提取总RNA并使用cDNA宏阵列检测mRNA表达谱。
层次聚类分析显示了一个树状图,其中患者被分为两个簇。一个簇由A组的7名患者和B组的2名患者组成。另一个簇由A组的2名患者和B组的8名患者组成。因此,层次聚类分析对肝转移的阳性预测值和阴性预测值分别为80.0%和78.8%。在B组中发现15个基因上调,12个基因下调。上调的基因包括CCNA2、TP53和MDM2,而下调的基因包括CDH1、GADD45A和BCL2L2。
通过对原发肿瘤标本进行cDNA阵列分析的mRNA表达谱分析被发现有助于区分有无肝转移的患者。该方法有望有助于识别肝转移复发高危患者,同时也有助于对这类高危患者进行强化辅助化疗。